Skip to content

A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05150028
Enrollment
16
Registered
2021-12-08
Start date
2023-04-11
Completion date
2024-06-06
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication Adherence

Brief summary

To develop a cancer center level practice intervention to promote treatment adherence and reduce outcome disparities in pediatric cancer survivors

Detailed description

To conduct a pilot study to assess the feasibility and acceptability of the Social Determinants of Adherence intervention

Interventions

BEHAVIORALPatient participation

Questionnaire

OTHERClinician barrier reports

How many times a 7 question Survey on medication education practices is opened

Sponsors

Roswell Park Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Parents/caregivers of pediatric patients must meet the following criteria to be eligible: * Parents/guardians of child that has been diagnosed with any cancer. * Parents/guardians of child with any cancer between age 0 and 18. * Parents/guardians of child on home-based oral anti-cancer therapy or supportive care therapy. * The clinician for the family agrees to participate in the study.

Exclusion criteria

* Participants will be excluded from this study if unwilling or unable to complete the assessment in English

Design outcomes

Primary

MeasureTime frameDescription
Retention ratesUp to 8 weeksFeasibility of intervention as assessed by retention rates

Secondary

MeasureTime frameDescription
Feasibility of universal SDOA screeningup to 8 weeksWill be assessed by results of SDOA questionnaire an 8 item questionnaire rated on a 5-point Likert scale (0-I never experienced this ; 5 - I experience this quite a lot)
Provider satisfaction with barrier reportsup to 8 weeksREDCap analytics will track the rate of opened barrier reports

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026